- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03. | EXACT Therapeutics AS: Share capital increase registered | 1 | Oslo Børs | ||
| 13.03. | EXACT Therapeutics AS - Minutes from extraordinary general meeting on 13 March 2026 | - | Oslo Børs | ||
| 03.03. | EXACT Therapeutics AS: EXACT Therapeutics - First patient dosed in Europe in Phase 2 trial in patients with locally advanced pancreatic cancer | 3 | Oslo Børs | ||
| 27.02. | EXACT Therapeutics AS: Notice of extraordinary general meeting | 2 | Oslo Børs | ||
| 27.02. | EXACT Therapeutics AS: Warrants exercise | - | Oslo Børs | ||
| EXACT THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 12.02. | EXACT Therapeutics AS: Financial calendar | - | Oslo Børs | ||
| 11.02. | EXACT Therapeutics AS: EXACT Therapeutics: Investor presentation for the global investor call regarding the ongoing warrants exercise program | 2 | Oslo Børs | ||
| 06.02. | EXACT Therapeutics AS: EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program | 1 | Oslo Børs | ||
| 05.02. | EXACT Therapeutics AS: EXACT Therapeutics: Correction of final warrants exercise date | 2 | Oslo Børs | ||
| 05.02. | EXACT Therapeutics AS: EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders | 2 | Oslo Børs | ||
| 05.02. | EXACT Therapeutics AS: EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB | 2 | Oslo Børs | ||
| 27.01. | EXACT Therapeutics AS: EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants | 1 | Oslo Børs | ||
| 08.01. | EXACT Therapeutics AS: EXACT Therapeutics' Phase 2 trial in pancreatic cancer patients to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium | - | Oslo Børs | ||
| 25.11.25 | EXACT Therapeutics AS: EXACT Therapeutics to present company update | 1 | Oslo Børs | ||
| 24.11.25 | EXACT Therapeutics AS: New option program and receipt of share options by primary insiders | 4 | Oslo Børs | ||
| 24.06.25 | Exact Therapeutics AS: EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer | 256 | GlobeNewswire (Europe) | OSLO, Norway, June 24, 2025 (GLOBE NEWSWIRE) -- EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, is pleased to announce first patient dosed in its ENACT trial.... ► Artikel lesen | |
| 20.05.25 | Exact Therapeutics AS: EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer | 377 | GlobeNewswire (Europe) | These results indicate that EXACT Therapeutics' Acoustic Cluster Therapy (ACT®) significantly enhances the local effect of chemotherapyIn the patients who had a response to chemotherapy, ACT-treated... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen EXACT THERAPEUTICS AS kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +39,81 % bei einem Aktienkurs von 0,144 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXACT THERAPEUTICS AS finden Sie auf Wallstreet Online.